Accountability of the pharmaceutical industry
- 1 November 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 360 (9346) , 1682-1684
- https://doi.org/10.1016/s0140-6736(02)11599-6
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- WHO: the casualties and compromises of renewalThe Lancet, 2002
- Drug companies neglect research into diseases affecting the poorBMJ, 2001
- Affordably priced new drugs for poor populations: Approaches for a global solutionInternational Journal of Risk & Safety in Medicine, 2001
- Drug development output: what proportion for tropical diseases?The Lancet, 1999
- Access to Essential Drugs in Poor CountriesA Lost Battle?JAMA, 1999